Dr. Melissa ZHANG has over 18 years of experience in venture capital investment, start-up and public company operations, and biomedical research in the life sciences industry in China. She also has working knowledge in company strategy, reorganization, M&A, IPO preparation, and corporate compliance.
Dr. Zhang is primarily responsible for deal sourcing, due diligence, structuring, and portfolio management for early stage bio-pharmaceutical companies to growth stage medical device and healthcare service companies. Prior to Cenova, Dr. Zhang was the Board Secretary and Senior Director of the Executive Office at Shanghai Genomics, a life science company listed on the Tokyo Stock Exchange.
Dr. Zhang received her M.D. from Fudan University Medical School.